BAXTER INTERNATIONAL INC. Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents
BAXTER INTERNATIONAL INC. (BAX) reported Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents of -$18.00 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Cash Flow › Change in Cash
us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2026-07-30
- BAXTER INTERNATIONAL INC. effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents for the quarter ending 2026-03-31 was -$18.00M, a 150.00% decline year-over-year.
- BAXTER INTERNATIONAL INC. effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents for the quarter ending 2025-03-31 was $36.00M.
- BAXTER INTERNATIONAL INC. effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents for the quarter ending 2024-03-31 was -$25.00M.
- BAXTER INTERNATIONAL INC. effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents for the quarter ending 2019-03-31 was -$1.00M, a 103.13% decline year-over-year.
- BAXTER INTERNATIONAL INC. effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents for fiscal 2023 was $26.00M.
- BAXTER INTERNATIONAL INC. effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents for fiscal 2022 was -$76.00M.
- BAXTER INTERNATIONAL INC. effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents for fiscal 2021 was -$47.00M, a 182.46% decline from fiscal 2020.
- BAXTER INTERNATIONAL INC. effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents for fiscal 2020 was $57.00M.
| Period end | Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 3 month | Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 6 month | Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 9 month | Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$18.00M 10-Q · filed 2026-07-30 | |||
| 2026-03-31 | -$18.00M 10-Q · filed 2026-04-30 | |||
| 2025-09-30 | $83.00M 10-Q · filed 2025-11-04 | |||
| 2025-06-30 | $88.00M 10-Q · filed 2026-07-30 | |||
| 2025-03-31 | $36.00M 10-Q · filed 2026-04-30 | |||
| 2024-09-30 | -$45.00M 10-Q · filed 2025-11-04 | |||
| 2024-06-30 | -$47.00M 10-Q · filed 2025-08-05 | |||
| 2024-03-31 | -$25.00M 10-Q · filed 2025-05-06 | |||
| 2023-12-31 | $26.00M 10-K · filed 2024-02-08 | |||
| 2023-09-30 | -$37.00M 10-Q · filed 2024-11-12 | |||
| 2022-12-31 | -$76.00M 10-K · filed 2024-02-08 | |||
| 2021-12-31 | -$47.00M 10-K · filed 2024-02-08 | |||
| 2020-12-31 | $57.00M 10-K · filed 2023-02-09 | |||
| 2019-12-31 | -$5.00M 10-K · filed 2022-02-23 | |||
| 2019-06-30 | $2.00M 10-K · filed 2020-03-17 | |||
| 2019-03-31 | -$1.00M 10-K · filed 2020-03-17 | |||
| 2018-12-31 | -$63.00M 8-K · filed 2021-04-29 | |||
| 2018-06-30 | -$38.00M 10-K · filed 2020-03-17 | |||
| 2018-03-31 | $32.00M 10-K · filed 2020-03-17 | |||
| 2017-12-31 | $102.00M 10-K · filed 2020-03-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| Heartflow, Inc. (HTFL) | United States | $4.225B |